Abstract
Research question
Is low MFN2 expression associated with ageing in granulosa cells as well as assisted
reproductive technology (ART) outcome, and what is the underlying mechanism of action
of MFN2?
Design
In a prospective study, fresh granulosa cells were obtained from 161 women aged 20–40
years who underwent IVF with embryo transfer and who were divided into two groups:
the diminished ovarian reserve (DOR) group (n = 51) and the control group (n = 110). Patient characteristics including age, infertility duration, body mass index,
FSH, anti-Müllerian hormone (AMH), antral follicle count (AFC) and husband's semen
parameters and granulosa cell MFN2 expression levels, cell apoptosis, mitochondrial
membrane potential (ΔΨm) and ATP levels were analysed.
Results
There were no significant differences between the DOR and control groups in terms
of age, infertility duration and husband’’ semen parameters; however, significant
(P< 0.05) changes were found between the two groups in FSH, AMH and AFC levels. MFN2
expression was remarkably lower in granulosa cells from the DOR group and decreased
in both groups as age increased. Furthermore, among young patients, MFN2 levels significantly
increased in patients with pregnancy. MFN2 protein levels and cell apoptosis were
lower in the MFN2 knockdown (MFN2-siRNA) group than in the control (Cy3-siRNA) group.
ΔΨm and ATP levels were reduced in the MFN2-siRNA group compared with the Cy3-siRNA
group.
Conclusions
Low MFN2 expression levels in granulosa cells were related to ageing, which may be
involved in the clinical outcome of ART by promoting cell apoptosis and affecting
mitochondrial function.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Reproductive BioMedicine OnlineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Disturbed mitochondrial dynamics and neurodegenerative disorders.Nat. Rev. Neurol. 2015; 11: 11-24
- Mitofusins Mfn1 and MFN2 coordinately regulate mitochondrial fusion and are essential for embryonic development.J Cell Biol. 2003; 160: 189-200
- Ca(2+) mobilization in cumulus cells: role in oocyte maturation and acrosome reaction.Cell Calcium. 2013; 53: 68-75
- Mfn2-Mediated Preservation of Mitochondrial Function Contributes to the Protective Effects of BHAPI in Response to Ischemia.J. Mol. Neurosci. 2017; 63: 267-274
- The role of mitochondrial function in the oocyte and embryo.Curr. Top Dev. Biol. 2007; 77: 21-49
- Changes in keratin 8/18 expression in human granulosa cell lineage are associated to cell death/survival events: potential implications for the maintenance of the ovarian reserve.Hum. Reprod. 2018; 33: 680-689
- Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.Cell Death Dis. 2016; 7: e2238
- Mitochondrial DNA content contributes to healthy ageing in Chinese: a study from nonagenarians and centenarians.Neurobiol. Ageing. 2014; 35 (e1–4): 1779
- Intraovarian control of early folliculogenesis.Endocr. Rev. 2015; 36: 1-24
- Mitochondrial fission and fusion.Biochem. Soc. Trans. 2016; 44: 1725-1735
- Mitofusin 2 regulates the oocytes development and quality by modulating meiosis and mitochondrial function.Sci. Rep. 2016; 6: 30561
- Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells.J. Reprod. Dev. 2012; 58: 44-50
- Initial and cyclic recruitment of ovarian follicles.Endocr. Rev. 2000; 21: 200-214
- New insights into the function and regulation of mitochondrial fission.Biochim. Biophys. Acta. 2013; 1833: 1256-1268
- Mitofusins: mighty regulators of metabolism.Cell. 2013; 155: 17-18
- Low expression of Mfn2 is associated with mitochondrial damage and apoptosis in the placental villi of early unexplained miscarriage.Placenta. 2013; 34: 613-618
- ‘What makes some rats live so long?’ The mitochondrial contribution to longevity through balance of mitochondrial dynamics and mtDNA content.Exp. Gerontol. 2016; 85: 33-40
- Bid and Bax are involved in granulosa cell apoptosis during follicular atresia in porcine ovaries.J. Reprod. Dev. 2011; 57: 421-427
- The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility.Reprod. Biol. Endocrinol. 2014; 12: 111
- Mitofusins, from Mitochondria to Metabolism.Mol. Cell. 2016; 61: 683-694
- Mitochondrial function in the human oocyte and embryo and their role in developmental competence.Mitochondrion. 2011; 11: 797-813
- Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins, and transcription factor GATA-4.J. Clin. Endocrinol. Metab. 2001; 86: 3421-3429
- The role of mitochondrial DNA copy number in mammalian fertility.Biol. Reprod. 2010; 83: 52-62
- Mitochondrial dynamics controlled by mitofusins define organelle positioning and movement during mouse oocyte maturation.Mol. Hum. Reprod. 2014; 20: 1090-1100
- MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons.J. Biol. Chem. 2015; 290: 168-182
- Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes.Endocrinology. 2013; 154: 3401-3409
- Mitofusin-2 is required for mouse oocyte meiotic maturation.Sci. Rep. 2016; 6: 30970
- Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles.Cell. Res. 2006; 16: 841-850
- Mitochondrial dynamics regulates migration and invasion of breast cancer cells.Oncogene. 2013; 32: 4814-4824
- Mfn2 Affects embryo development via mitochondrial dysfunction and apoptosis.PLoS One. 2015; 10e0125680
Biography

Article info
Publication history
Published online: December 14, 2018
Accepted:
October 23,
2018
Received in revised form:
October 20,
2018
Received:
June 5,
2018
Declaration: The authors report no financial or commercial conflicts of interest.Identification
Copyright
© 2018 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.